Sterling Capital Management LLC Sells 260 Shares of Relx Plc (NYSE:RELX)

Sterling Capital Management LLC cut its stake in shares of Relx Plc (NYSE:RELX) by 2.4% during the fourth quarter, HoldingsChannel reports. The firm owned 10,426 shares of the technology company’s stock after selling 260 shares during the quarter. Sterling Capital Management LLC’s holdings in Relx were worth $474,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of RELX. Private Trust Co. NA raised its holdings in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company’s stock worth $56,000 after buying an additional 199 shares during the period. Sage Mountain Advisors LLC lifted its position in shares of Relx by 5.1% during the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company’s stock worth $240,000 after purchasing an additional 258 shares during the last quarter. DRW Securities LLC boosted its stake in shares of Relx by 5.9% during the fourth quarter. DRW Securities LLC now owns 4,652 shares of the technology company’s stock valued at $211,000 after purchasing an additional 259 shares during the period. Peapack Gladstone Financial Corp increased its stake in Relx by 5.7% in the 3rd quarter. Peapack Gladstone Financial Corp now owns 4,924 shares of the technology company’s stock worth $234,000 after buying an additional 267 shares during the period. Finally, Marks Group Wealth Management Inc lifted its holdings in Relx by 1.3% during the 4th quarter. Marks Group Wealth Management Inc now owns 26,196 shares of the technology company’s stock valued at $1,190,000 after buying an additional 325 shares in the last quarter. 15.02% of the stock is owned by institutional investors.

Relx Price Performance

Shares of RELX stock opened at $52.20 on Friday. The company has a market cap of $96.61 billion, a P/E ratio of 28.06, a PEG ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The stock’s 50-day moving average is $49.37 and its 200 day moving average is $48.00. Relx Plc has a 1-year low of $40.25 and a 1-year high of $52.54.

Relx Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Friday, May 9th will be given a $0.5586 dividend. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. This is an increase from Relx’s previous semi-annual dividend of $0.23. Relx’s payout ratio is presently 59.68%.

Analysts Set New Price Targets

A number of brokerages have recently commented on RELX. Barclays raised shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock. The Goldman Sachs Group initiated coverage on Relx in a report on Wednesday, March 26th. They issued a “buy” rating for the company. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research report on Wednesday. Finally, StockNews.com cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.